Hara H, Ayata C, Huang P L, Waeber C, Ayata G, Fujii M, Moskowitz M A
Department of Neurosurgery and Neurology, Massachusetts General Hospital, Harvard Medical School, Charlestown 02129, USA.
J Cereb Blood Flow Metab. 1997 May;17(5):515-26. doi: 10.1097/00004647-199705000-00005.
We investigated the density and distribution of nitric oxide synthase (NOS) binding by quantitative autoradiography using [3H]L-NG-nitroarginine ([3H]L-NNA) after transient focal ischemia or intrastriatal injection of N-methyl-D-aspartate (NMDA) in wild-type (SV-129 and C57black/6) and type I (neuronal) and type III (endothelial) NOS-deficient mice. The middle cerebral artery (MCA) was occluded by an intraluminal filament for 3 h followed by 10 min to 7 days of reperfusion. Specific [3H]L-NNA binding, observed in the wild-type and type III mutant mouse at baseline, increased by 50-250% in the MCA territory during ischemia and the first 3 h of reperfusion. The density of binding sites (Bmax), but not the dissociation constant (Kd), increased significantly during the ischemic period as did type I NOS mRNA as detected by quantitative reverse transcription polymerase chain reaction. [3H]L-NNA binding after intrastriatal NMDA injection also increased by 20-230%. In the type I NOS-deficient mouse, [3H]L-NNA binding was low and only a very small increase was observed after ischemia or excitotoxicity. Under conditions of this study, [3H]L-NNA did not bind to type II NOS as there was no difference in the distribution or density of [3H]L-NNA binding in the rat spleen obtained after lipopolysaccharide treatment despite induction of NOS type II catalytic activity. Our data suggest that an ischemic/excitotoxic insult up-regulates type I NOS gene expression and [3H]L-NNA binding and that this up-regulation may play a pivotal role in the pathogenesis of ischemic/excitotoxic diseases.
我们通过定量放射自显影术,使用[3H]L-硝基精氨酸([3H]L-NNA),研究了野生型(SV-129和C57黑/6)以及I型(神经元型)和III型(内皮型)一氧化氮合酶(NOS)缺陷小鼠在短暂局灶性缺血或纹状体内注射N-甲基-D-天冬氨酸(NMDA)后NOS结合的密度和分布情况。通过腔内细丝闭塞大脑中动脉(MCA)3小时,随后再灌注10分钟至7天。在野生型和III型突变小鼠基线时观察到的特异性[3H]L-NNA结合,在缺血期间和再灌注的最初3小时内,在MCA区域增加了50%-250%。结合位点的密度(Bmax),而非解离常数(Kd),在缺血期显著增加,定量逆转录聚合酶链反应检测到的I型NOS mRNA也增加。纹状体内注射NMDA后的[3H]L-NNA结合也增加了20%-230%。在I型NOS缺陷小鼠中,[3H]L-NNA结合较低,缺血或兴奋性毒性后仅观察到非常小的增加。在本研究条件下,[3H]L-NNA不与II型NOS结合,因为尽管诱导了II型NOS催化活性,但脂多糖处理后获得的大鼠脾脏中[3H]L-NNA结合的分布或密度没有差异。我们的数据表明,缺血/兴奋性毒性损伤上调I型NOS基因表达和[3H]L-NNA结合,并且这种上调可能在缺血/兴奋性毒性疾病的发病机制中起关键作用。